Vantis GmbH is a Digital solution for Chronic cardiovascular diseases that requires personalized ongoing treatment for decades.
Vantis has raised €14M across 2 funding rounds from 8 investors, most recently a Series A round in Mar 2025. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-03-12 | Series A | €10M | Angelini Ventures,b2venture ,Bayern Kapital,Existing investors,firstminute capital,Twip Impact Ventures | View deal → |
| 2021-05-03 | Other | €3.8M | Angel Investors,btov Partners | View deal → |
